Arthritis Research & Therapy

official impact factor 4.36

This article is part of the supplement: The Scientific Basis of Rheumatology

Email this article to a friend

Engineering of tissue inhibitor of metalloproteinases mutants as potential therapeutics

Hideaki Nagase* and Keith Brew

Arthritis Res 2002, 4(Suppl 3):S51-S61 doi:10.1186/ar573


London, UK. 24-26 June 2002

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.